Ligand Pharma up on raised 2022 sales forecast

Ligand Pharmaceuticals Incorporated

08/11/2022 17:22

** Shares of Ligand Pharmaceuticals Inc  LGND.O  rise 14.7%
to $72.12 
    ** Biotechnology firm late on Monday raised 2022 sales
guidance to $184 mln-$189 mln vs previous range of $133 mln-$146
mln
    ** Co posted Q3 adjusted profit of $1.31 per share, beating
analysts' estimates of $0.43 per share - Refinitiv IBES data
    ** Including session gains, stock has fallen ~25% YTD
 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))